An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Sophie CapdepontGECSA

Abstract

To assess the genotypic determinants of the virological response (VR) to didanosine (ddI) in nucleoside reverse transcriptase inhibitors (NRTI)-experienced patients. Human immunodeficiency virus type 1 (HIV-1) genotype was determined at baseline in 74 ddI-naive-patients with baseline viral load >500 copies/ml and receiving ddI as part of a new regimen. VR was defined as a plasma HIV-1 RNA <50 copies/ml after three months on ddI. NRTI resistance mutations associated with higher or lower frequencies of VR with a p-value<0.25 were retained in different sets of mutations, where the mutations associated with a worse VR were added, whereas the mutations associated with a better VR were subtracted. The most significant mutation scores were then studied in a multivariate analysis. Changes at three codons (M41L, L210W, T215Y/F/D/C/E) were associated with a worse VR and three mutations (K70R, M184V, K219Q) with a better VR. The strongest association with the VR was obtained with the score M41L+L210W+T215Y/F/D/C/E-K70R-K219Q. The score was independently associated with the VR in the multivariate analysis. Taking into account the mutations associated with a better VR may improve genotypic resistance algorithms. Our results are of interest ...Continue Reading

References

Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T ShirasakaR Yarchoan
May 17, 2001·Antimicrobial Agents and Chemotherapy·B MasquelierUNKNOWN ANRS AC11 Resistance study group. French Agence Nationale de Recherches sur le SIDA
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Aug 5, 2003·The Journal of Infectious Diseases·Mark A WintersUNKNOWN AIDS Clinical Trials Group 364 Study Team
Sep 27, 2003·The Journal of Infectious Diseases·Jeannette M WhitcombChristos J Petropoulos
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Anne-Geneviève MarcelinUNKNOWN AI454-176 Jaguar Study Team

❮ Previous
Next ❯

Citations

Oct 30, 2009·AIDS·Lambert AssoumouUNKNOWN Standardization, Clinical Relevance of HIV Drug Resistance Testing Project from the Forum for Collaborative HIV Research
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurence GérardEric Oksenhendler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.